SCHEMBL8577014

SCHEMBL8577014

O=C(O)c1ccc(C(=O)O)c(C(=O)O)c1Cc1c(C(=O)O)ccc(C(=O)O)c1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
KLKB1 P03952 1/20 0.42
CTSB P07858 1/20 0.42
MMP9 P14780 1/20 0.42
DNMT1 P26358 1/20 0.42
DNMT3B Q9UBC3 1/20 0.42
DNMT3L Q9UJW3 1/20 0.42
DNMT3A Q9Y6K1 1/20 0.42
AKR1C3 P42330 2/20 0.41
ALDH1A1 P00352 5/20 0.41
CDC25B P30305 3/20 0.41
CDC25A P30304 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CASP6 P55212 1/20 0.41
RCE1 Q9Y256 1/20 0.41
TSHR P16473 3/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GPR35 Q9HC97 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL106659 0.86 CYP1A2 (0.46) CYP1A2KLKB1CTSBMMP9DNMT1
SCHEMBL29921822 0.86 HNF4A (0.51) AKR1C3ALDH1A1CDC25BCDC25AHSD17B10
SCHEMBL7198373 0.83 CYP1A2 (0.39) CYP1A2KLKB1CTSBMMP9DNMT1
SCHEMBL5134495 0.82 GABRP (0.43) CYP1A2KLKB1CTSBMMP9DNMT1
SCHEMBL9547628 0.82 CYP1A2 (0.42) CYP1A2KLKB1CTSBMMP9DNMT1
SCHEMBL9547569 0.82 CYP1A2 (0.42) CYP1A2KLKB1CTSBMMP9DNMT1
SCHEMBL9547567 0.80 PPARA (0.41) CYP1A2ALDH1A1ALOX15
SCHEMBL9547631 0.80 PPARA (0.41) CYP1A2ALDH1A1ALOX15
SCHEMBL22989 0.79 CYP1A2 (0.61) CYP1A2AKR1C3ALDH1A1CDC25BCDC25A
SCHEMBL1988762 0.79 CYP1A2 (0.61) CYP1A2AKR1C3ALDH1A1CDC25BCDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5792840-A SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES SANKYO COMPANY, LIMITED (JP) 1998-08-11 US disclosed
EP-0437016-B1 Lipid A analogues having immunoactivating and anti-tumour activity SANKYO CO (JP) 1996-05-01 EP disclosed
EP-0308270-B1 Processes for preparation of polyimide-isoindoquinazoline dione and precursor thereof HITACHI CHEMICAL CO LTD (JP) 1993-12-08 EP disclosed
EP-0437016-A2 Lipid A analogues having immunoactivating and anti-tumour activity Sankyo Company Limited (JP) 1991-07-17 EP disclosed
EP-0308270-A2 Processes for preparation of polyimide-isoindoquinazoline dione and precursor thereof Hitachi Chemical Co., Ltd. (JP) 1989-03-22 EP disclosed